实用肝脏病杂志
實用肝髒病雜誌
실용간장병잡지
JOURNAL OF CLINICAL HEPATOLOGY
2013年
4期
332-334
,共3页
HepG2细胞%格尔德霉素%增殖%调亡
HepG2細胞%格爾德黴素%增殖%調亡
HepG2세포%격이덕매소%증식%조망
HepG2 cells%Geldanamycin%Proliferation%Apoptosis
目的研究格尔德霉素对人肝癌HepG2细胞增殖及凋亡的影响。方法不同浓度格尔德霉素与人肝癌HepG2细胞共培养,采用MTT法检测增殖抑制率;采用流式细胞术Annexin V法检测细胞凋亡率。结果在0.2、0.4和0.8μmol/L浓度下,格尔德霉素均显著抑制HepG2细胞的增殖,在干预细胞48h后,其抑制率分别为20.36%、29.45%和42.52%,抑制率随药物浓度增加而升高;同时,细胞凋亡率分别为4.82%、24.47%和53.64%,也呈剂量依赖性,与相应对照组比,差异有统计学意义(P<0.05)。结论格尔德霉素可抑制肝癌HepG2细胞增殖并诱导其调亡。
目的研究格爾德黴素對人肝癌HepG2細胞增殖及凋亡的影響。方法不同濃度格爾德黴素與人肝癌HepG2細胞共培養,採用MTT法檢測增殖抑製率;採用流式細胞術Annexin V法檢測細胞凋亡率。結果在0.2、0.4和0.8μmol/L濃度下,格爾德黴素均顯著抑製HepG2細胞的增殖,在榦預細胞48h後,其抑製率分彆為20.36%、29.45%和42.52%,抑製率隨藥物濃度增加而升高;同時,細胞凋亡率分彆為4.82%、24.47%和53.64%,也呈劑量依賴性,與相應對照組比,差異有統計學意義(P<0.05)。結論格爾德黴素可抑製肝癌HepG2細胞增殖併誘導其調亡。
목적연구격이덕매소대인간암HepG2세포증식급조망적영향。방법불동농도격이덕매소여인간암HepG2세포공배양,채용MTT법검측증식억제솔;채용류식세포술Annexin V법검측세포조망솔。결과재0.2、0.4화0.8μmol/L농도하,격이덕매소균현저억제HepG2세포적증식,재간예세포48h후,기억제솔분별위20.36%、29.45%화42.52%,억제솔수약물농도증가이승고;동시,세포조망솔분별위4.82%、24.47%화53.64%,야정제량의뢰성,여상응대조조비,차이유통계학의의(P<0.05)。결론격이덕매소가억제간암HepG2세포증식병유도기조망。
Objective To investigate the effects of geldanamycin on the proliferation and apoptosis in hu-man hepatoma cell lines HepG2. Methods HepG2 cells were incubated with different concentrations of gel-danamycin for 24 to 72 hours. Cell proliferation was determined by MTT assay. Cell apoptosis was detected by flow cytometry using annexin V and propidium iodide. Results Geldanamycin significantly inhibited the prolifera-tion of HepG2 cells at a dose-dependent manner. When compared to the control,the cell proliferation was inhibit-ed by 20.36%,29.45% and 42.52%,respectively after 48h incubation at the concentration of 0.2,0.4 and 0.8μmol/L of geldanamycin,however,the apoptosis of HepG2 cells was increased by 4.82%,24.47% and 53.64%(P<0.05). Conclusions Geldanamycin inhibits proliferation and induces apoptosis in HepG2 cells,suggesting a therapeutic effect of geldanamycin in hepatoma treatment.